{
    "id": 27385,
    "fullName": "DDR2 over exp",
    "impact": "none",
    "proteinEffect": "no effect",
    "geneVariantDescriptions": [
        {
            "description": "DDR2 over exp indicates an over expression of the Ddr2 protein and/or mRNA. However, the mechanism causing the over expression is unspecified.",
            "references": [
                {
                    "id": 275,
                    "pubMedId": null,
                    "title": "External Reference Not Available (N/A)",
                    "url": "https://ckb.jax.org/about/glossaryOfTerms"
                }
            ]
        }
    ],
    "type": "non-specific",
    "gene": {
        "id": 4921,
        "geneSymbol": "DDR2",
        "terms": [
            "DDR2",
            "MIG20a",
            "NTRKR3",
            "TKT",
            "TYRO10",
            "WRCN"
        ]
    },
    "variant": "over exp",
    "createDate": "01/10/2018",
    "updateDate": "01/10/2018",
    "referenceTranscriptCoordinates": null,
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 12670,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, Sprycel (dasatinib) inhibited cell migration and invasion of head and neck squamous cell carcinoma cells overexpressing Ddr2, in culture (PMID: 27434411).",
            "molecularProfile": {
                "id": 28831,
                "profileName": "DDR2 over exp"
            },
            "therapy": {
                "id": 717,
                "therapyName": "Dasatinib",
                "synonyms": null
            },
            "indication": {
                "id": 5520,
                "name": "head and neck squamous cell carcinoma",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 10581,
                    "pubMedId": 27434411,
                    "title": "Targeting DDR2 in head and neck squamous cell carcinoma with dasatinib.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/27434411"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 28831,
            "profileName": "DDR2 over exp",
            "profileTreatmentApproaches": [
                {
                    "id": 16668,
                    "name": "DDR2 inhibitor",
                    "profileName": "DDR2 over exp"
                }
            ]
        }
    ],
    "allTranscriptCoordinates": [
        
    ]
}